CompletedNot Applicable

The Relationship Among Sarcopenia, Preperitoneal Fat Thickness and Cholecystectomy

Turkey (Türkiye)158 participantsStarted 2024-03-20

Plain-language summary

The aim of this study was to examine the relationship between sarcopenia and visceral adiposity in participants with and without cholecystectomy. In this way, the long-term effects of cholecystectomy operations, which are commonly performed in the society and thought to be harmless, will be evaluated.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Cholecystectomy at least 5 years ago * control group; those without cholecystectomy Exclusion Criteria: * Advanced cardiac, hepatic and renal insufficiency, * active malignancies (currently or within the last one year receiving radiotherapy/chemotherapy), * rheumatological diseases, * severe knee, hip and hand osteoarthritis, * use of any assistive device for walking, * neuromuscular diseases (motor neuron diseases, polyneuropathies, myasthenia gravis), * major depression, * Parkinson's disease, previous stroke, cerebellar diseases and multiple sclerosis were excluded.

What they're measuring

STAR values

Timeframe: through study completion, an average of 4 months

low grip strength

Timeframe: through study completion, an average of 4 months

chair stand test duration

Timeframe: through study completion, an average of 4 months

visceral adipose tissue thickness

Timeframe: through study completion, an average of 4 months

Subcutaneous maximum fat thickness

Timeframe: through study completion, an average of 4 months

Subcutaneous minimum fat thickness

Timeframe: through study completion, an average of 4 months

Preperitoneal fat thickness

Timeframe: through study completion, an average of 4 months

Trial details

NCT IDNCT06468735

SponsorDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-19

View on ClinicalTrials.gov More Sarcopenia trials

Plain-language summary

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

STAR values

Timeframe: through study completion, an average of 4 months

low grip strength

Timeframe: through study completion, an average of 4 months

chair stand test duration

Timeframe: through study completion, an average of 4 months

visceral adipose tissue thickness

Timeframe: through study completion, an average of 4 months

Subcutaneous maximum fat thickness

Timeframe: through study completion, an average of 4 months

Subcutaneous minimum fat thickness

Timeframe: through study completion, an average of 4 months

Preperitoneal fat thickness

Timeframe: through study completion, an average of 4 months